dose-dependent_manner	Other
oncosphere_of_tapeworm_Echinococcus	Other
normal_cell_growth	Other
cell_cycle	Other
significant_tumor_growth_reduction	Other
promise	Other
manner	Other
anti-cancer_therapeutic	Other
cancer_cell_growth	Other
tumor_growth_reduction_in_mice	Other
therapeutic	Other
oncosphere_of_canine_tapeworm_Echinococcus	Other
significant_tumor_growth_reduction_in_EgKI-1-treated_mice	Other
oncosphere	Other
BALB/c_nude_mice	Other
expressed	Other
EgKI-1-treated_mice	Other
future_development	Other
highly_expressed	Other
tumor_growth_reduction_in_EgKI-1-treated_mice	Other
cancer_cells	Other
cell_growth	Other
tumor_growth_reduction	Other
migration	Other
growth	Other
promise_for_future_development	Other
significant_tumor_growth_reduction_in_mice	Other
personal_goals	Other
existing_evidence	Other
evidence_on_goal-setting	Other
study	Other
evidence	Other
existing_evidence_on_personal_goal-setting_among_women_with_breast_cancer_diagnosis	Other
insight_into_their_priorities	Other
breast_cancer_diagnosis	Other
interventions_for_care	Other
evidence_on_goal-setting_among_women	Other
where_major_component	Other
existing_evidence_on_personal_goal-setting	Other
major_component	Other
major	Other
where_component	Other
where_major_component_of_study	Other
context	Other
studies	Other
effective_interventions	Other
goal-setting	Other
existing_evidence_on_personal_goal-setting_among_women	Other
context_of_breast_cancer	Other
evidence_on_personal_goal-setting	Other
females	Other
existing_evidence_on_goal-setting_among_women	Other
personal_goal-setting	Other
evidence_on_goal-setting_among_women_with_breast_cancer_diagnosis	Other
evidence_on_personal_goal-setting_among_women_with_breast_cancer_diagnosis	Other
breast_cancer	Other
searched	Other
insight	Other
component	Other
interventions	Other
evidence_on_personal_goal-setting_among_women	Other
existing_evidence_on_goal-setting	Other
existing_evidence_on_goal-setting_among_women_with_breast_cancer_diagnosis	Other
where_component_of_study	Other
effective_interventions_for_care	Other
support	Other
anti-proliferative_effects_of_tamoxifen	Other
potential_mechanisms	Other
expression_of_mitochondrial_proteins	Other
transcription	Other
combinatorial_effects	Other
co-treatment_of_tamoxifen	Other
cell_cycle	Other
when_exposed_to_tamoxifen	Other
cell_apoptosis	Other
combinatorial_anti-proliferative_effects_on_ER_cancer	Other
manner	Other
effects_on_ER_cancer	Other
G2/M_phase	Other
cell_proliferation	Other
anti-proliferative_effects_of_tamoxifen_on_ER_cancer	Other
shown	Other
in_model	Other
cell_growth_at_concentrations	Other
model	Other
ERα66	Other
combinatorial_effects_of_tamoxifen_on_ER_cancer	Other
tamoxifen	Chemical
potential_mechanisms_involved_in_mitochondrial_dysfunction_mediated_by_several_estrogen_receptor_subtypes	Other
present_study	Other
diseases	Other
co-treatment	Other
them	Other
effects_of_tamoxifen	Other
potential_mechanisms_involved_in_dysfunction_mediated_by_several_estrogen_receptor_subtypes	Other
expression_of_apoptotic_proteins	Other
ER_cancer	Other
anti-proliferative_effects	Other
potential_mechanisms_involved_in_dysfunction_mediated_by_estrogen_receptor_subtypes	Other
effects	Other
cell_growth	Other
expression_of_mitochondrial_apoptotic_proteins	Other
potential_mechanisms_involved_in_mitochondrial_dysfunction_mediated_by_estrogen_receptor_subtypes	Other
additive_manner	Other
potential_mechanisms_involved_in_mitochondrial_dysfunction	Other
combinatorial_effects_on_ER_cancer	Other
anti-proliferative_effects_on_ER_cancer	Other
most_diagnosed_diseases	Other
study	Other
cell_growth_at_higher_concentrations	Other
death	Disease
MCF-7	Other
combinatorial_anti-proliferative_effects_of_tamoxifen	Other
transcription_of_cell_cycle_regulation_proteins	Other
cell_growth_of_MCF-7_cells	Other
single_tamoxifen	Other
potential_mechanisms_involved_in_dysfunction	Other
combinatorial_effects_of_tamoxifen	Other
expression_of_proteins	Other
potential_mechanisms_involved	Other
exposed	Other
potential_mechanisms_involved_in_dysfunction_mediated	Other
cases	Other
expression	Other
females	Other
combinatorial_anti-proliferative_effects_of_tamoxifen_on_ER_cancer	Other
cell_growth_of_MCF-7_cells_at_higher_concentrations	Other
effects_of_tamoxifen_on_ER_cancer	Other
combinatorial_anti-proliferative_effects	Other
cell_migration	Other
potential_mechanisms_involved_in_mitochondrial_dysfunction_mediated	Other
cell_growth_of_MCF-7_cells_at_concentrations	Other
when_exposed_to_single_tamoxifen	Other
diagnosed_diseases	Other
when_exposed	Other
patient-based_4D_breast_phantom_including_time-varying_contrast_enhancement	Other
4D_breast_phantom_including_contrast_enhancement_for_simulation	Other
breast_CT_image	Other
vary	Other
realistic_patient-based_4D_breast_phantom_including_contrast_enhancement_for_simulation	Other
4D_digital_breast_phantom_including_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
patient-based_4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
healthy_patient	Other
convolution_between_arterial_input_function	Other
information_of_breast_resulting_in_detection_diagnosis_of_breast_cancer	Other
realistic_patient-based_4D_digital_breast_phantom_including_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
realistic_4D_breast_phantom	Other
realistic_4D_breast_phantom_including_contrast_enhancement_for_simulation	Other
healthy_patient_into_skin_fibroglandular_tissue_adipose_tissue	Other
breast_tissue_perfusion	Other
can_used_during_development_of_dynamic_contrast-enhanced_breast_CT_imaging	Other
realistic_4D_digital_breast_phantom_including_contrast_enhancement	Other
4D_digital_breast_phantom_including_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
expected_enhancement_of_tissues_consistent	Other
vary_on_voxel-basis	Other
work	Other
sampling	Other
4D_breast_phantom_including_time-varying_contrast_enhancement	Other
4D_breast_CT_image_acquisition	Other
functional_information_of_breast_resulting_in_detection_diagnosis_with_breast_CT.	Other
can_used_during_development_of_contrast-enhanced_breast_CT_imaging_for_optimization_of_image_acquisition_image_reconstruction	Other
can_used_during_development_of_dedicated_breast_CT_imaging_for_optimization	Other
can_used_during_development_of_dynamic_breast_CT_imaging	Other
realistic_4D_digital_breast_phantom_including_time-varying_contrast_enhancement	Other
realistic_4D_breast_phantom_including_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
patient-based_4D_breast_phantom_including_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
realistic_patient-based_4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation	Other
patient-based_4D_breast_phantom_including_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
computed_for_voxel_in_phantom	Other
4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation	Other
enhancement_of_tissues_consistent_with_given_input_parameters	Other
can_used_during_development_of_dynamic_contrast-enhanced_dedicated_breast_CT_imaging	Other
can_used_during_development_of_dynamic_contrast-enhanced_dedicated_breast_CT_imaging_for_optimization_of_image_acquisition_image_reconstruction	Other
realistic_patient-based_4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation	Other
can_used_during_development	Other
realistic_4D_digital_breast_phantom_including_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
patient-based_4D_digital_breast_phantom_including_time-varying_contrast_enhancement	Other
different_types_of_breast_lesions	Other
patient-based_4D_breast_phantom_including_contrast_enhancement	Other
4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
enhancement_of_tissues_consistent	Other
4D_breast_phantom_including_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
functional_information_of_breast	Other
example	Other
realistic_patient-based_4D_breast_phantom_including_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
can_used_during_development_of_contrast-enhanced_dedicated_breast_CT_imaging_for_optimization_of_image_acquisition_image_reconstruction	Other
realistic_4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation	Other
realistic_patient-based_4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
can_used_during_development_of_breast_CT_imaging_for_optimization_of_image_acquisition_image_reconstruction	Other
voxel_size_of_273_μm	Other
can_used_during_development_for_optimization_of_image_acquisition_image_reconstruction	Other
4D_breast_phantom	Other
convolution_between_input_function	Other
expected_enhancement_of_tissues	Other
4D_digital_breast_phantom_including_time-varying_contrast_enhancement	Other
perfusion	Other
can_used_during_development_of_breast_CT_imaging	Other
Finally_produced	Other
information_of_breast_resulting_in_detection_diagnosis_with_breast_CT.	Other
can_also_simulated_for_tumor_models	Other
patient-based_4D_breast_phantom_including_contrast_enhancement_for_simulation	Other
4D_digital_breast_phantom_including_contrast_enhancement_for_simulation	Other
4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation	Other
can_used_during_development_of_dynamic_dedicated_breast_CT_imaging_for_optimization_of_image_acquisition_image_reconstruction	Other
patient-based_4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation	Other
voxel	Other
enhancement_dynamics	Other
can_simulated	Other
realistic_4D_breast_phantom_including_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
information	Other
healthy_patient_into_skin_tissue_adipose_tissue	Other
dimensions	Other
information_of_breast_resulting_in_detection_diagnosis_of_breast_cancer_with_breast_CT.	Other
functional_information_of_breast_resulting_in_detection_diagnosis_of_breast_cancer_with_breast_CT.	Other
expected_enhancement	Other
patient_into_skin_tissue_adipose_tissue	Other
added	Other
patient-based_4D_digital_breast_phantom_including_contrast_enhancement_for_simulation	Other
patient_into_skin_fibroglandular_tissue_adipose_tissue	Other
can_used_during_development_of_dynamic_contrast-enhanced_dedicated_breast_CT_imaging_for_optimization	Other
realistic_4D_digital_breast_phantom	Other
used	Other
enhancement	Other
developed	Other
realistic_patient-based_4D_digital_breast_phantom_including_contrast_enhancement	Other
functional_information	Other
realistic_patient-based_4D_digital_breast_phantom	Other
realistic_4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
realistic_patient-based_4D_breast_phantom_including_contrast_enhancement	Other
patient-based_4D_digital_breast_phantom_including_contrast_enhancement	Other
can_used_during_development_of_contrast-enhanced_breast_CT_imaging_for_optimization	Other
functional_information_of_breast_resulting_in_detection_diagnosis_of_breast_cancer	Other
perfusion_in_types	Other
realistic_patient-based_4D_breast_phantom	Other
can_simulated_for_tumor_models	Other
4D_digital_breast_phantom_including_contrast_enhancement	Other
realistic_patient-based_4D_digital_breast_phantom_including_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
dimensions_of	Other
can_used_during_development_of_contrast-enhanced_dedicated_breast_CT_imaging_for_optimization	Other
calculated	Other
breast_CT.	Other
first_created	Other
4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
realistic_4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation	Other
perfusion_in_types_of_breast_lesions	Other
realistic_4D_breast_phantom_including_contrast_enhancement	Other
can_used_during_development_of_contrast-enhanced_dedicated_breast_CT_imaging	Other
can_used_during_development_of_dedicated_breast_CT_imaging	Other
created	Other
realistic_patient-based_4D_digital_breast_phantom_including_time-varying_contrast_enhancement	Other
patient-based_4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
functional_information_of_breast_resulting	Other
produced	Other
realistic_patient-based_4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
4D_breast_phantom_including_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
phantom	Other
perfusion_parameters	Other
patient-based_4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation	Other
4D_breast_phantom_including_contrast_enhancement	Other
perfusion_in_different_types_of_breast_lesions	Other
realistic_4D_breast_phantom_including_time-varying_contrast_enhancement	Other
perfusion_parameters_associated_with_tissue_voxel	Other
realistic_4D_digital_breast_phantom_including_contrast_enhancement_for_simulation	Other
realistic_4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
can_used	Other
can_used_during_development_of_dynamic_dedicated_breast_CT_imaging_for_optimization	Other
can_used_during_development_of_dynamic_dedicated_breast_CT_imaging	Other
can_modified	Other
4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
can_also_simulated	Other
realistic_4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
can_used_during_development_of_dedicated_breast_CT_imaging_for_optimization_of_image_acquisition_image_reconstruction	Other
realistic_4D_digital_breast_phantom_including_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
different_enhancement_dynamics	Other
patient-based_4D_breast_phantom	Other
perfusion_in_different_types	Other
expected_enhancement_of_tissues_consistent_with_given_input_parameters	Other
functional_information_of_breast_resulting_in_detection_diagnosis	Other
can_used_during_development_of_dynamic_contrast-enhanced_breast_CT_imaging_for_optimization	Other
realistic_patient-based_4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
patient-based_4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
enhancement_of_tissues_consistent_with_input_parameters	Other
information_of_breast_resulting	Other
can_used_during_development_of_dynamic_breast_CT_imaging_for_optimization	Other
can_used_during_development_of_contrast-enhanced_breast_CT_imaging	Other
patient	Species
convolution	Other
realistic_patient-based_4D_digital_breast_phantom_including_contrast_enhancement_for_simulation	Other
enhancement_of_tissues	Other
information_of_breast_resulting_in_detection_diagnosis	Other
voxel-basis	Other
patient-based_4D_digital_breast_phantom_including_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
can_used_during_development_of_breast_CT_imaging_for_optimization	Other
expected_enhancement_of_tissues_consistent_with_input_parameters	Other
4D_digital_breast_phantom	Other
realistic_4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
realistic_patient-based_4D_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
realistic_patient-based_4D_breast_phantom_including_time-varying_contrast_enhancement	Other
can_used_during_development_of_dynamic_contrast-enhanced_breast_CT_imaging_for_optimization_of_image_acquisition_image_reconstruction	Other
realistic_patient-based_4D_breast_phantom_including_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
can_used_during_development_of_dynamic_breast_CT_imaging_for_optimization_of_image_acquisition_image_reconstruction	Other
patient-based_4D_digital_breast_phantom_including_time-varying_contrast_enhancement_for_simulation_of_breast_CT_perfusion_imaging	Other
can_used_during_development_for_optimization	Other
patient-based_4D_digital_breast_phantom	Other
breast	Other
patient-based_4D_digital_breast_phantom_including_contrast_enhancement_for_simulation_of_dedicated_breast_CT_perfusion_imaging	Other
information_of_breast	Other
activities_of_O._pallidus	Other
antioxidant_scavenging_against_human_breast-cancer_cell_lines	Other
potent_activity_in_in-vitro_models	Other
excellent_antioxidant_antimicrobial	Other
increasing_OPAE_concentration	Other
free-radical_scavenging_against_breast-cancer_cell_lines	Other
investigated	Other
antioxidant_scavenging_against_human_cell_lines	Other
models	Other
human_cell_lines	Other
cell_lines	Other
DPPH	Chemical
antioxidant_antimicrobial	Other
excellent_antimicrobial	Other
antioxidant_scavenging_against_breast-cancer_cell_lines	Other
free-radical_scavenging_against_human_cell_lines	Other
different_models	Other
scavenging_against_human_breast-cancer_cell_lines	Other
3	Other
power_activities	Other
determined	Other
anticancer_activities	Other
potent_activity_in_models	Other
antioxidant_scavenging	Other
antimicrobial	Other
1_1-diphenyl-2-picrylhydrazyl	Other
free-radical_scavenging_against_human_breast-cancer_cell_lines	Other
activity	Other
human_breast-cancer_cell_lines	Other
antioxidant_free-radical_scavenging_against_breast-cancer_cell_lines	Other
scavenging_against_breast-cancer_cell_lines	Other
OPAE_concentration_up_to_240_g/mL	Other
anticancer	Other
anticancer_activities_of_O._pallidus	Other
antioxidant_free-radical_scavenging_against_human_breast-cancer_cell_lines	Other
increasing_OPAE_concentration_up_to_240_g/mL	Other
antioxidant_scavenging_against_cell_lines	Other
popular	Other
potent_activity	Other
breast-cancer_cell_lines	Other
antioxidant_free-radical_scavenging_against_cell_lines	Other
scavenging_against_human_cell_lines	Other
OPAE_concentration	Other
scavenging_against_cell_lines	Other
in-vitro_models	Other
free-radical_scavenging_against_cell_lines	Other
free-radical_scavenging	Other
activity_in_in-vitro_models	Other
activities	Other
antioxidant_free-radical_scavenging_against_human_cell_lines	Other
scavenging	Other
antioxidant_free-radical_scavenging	Other
activity_in_models	Other
two_groups	Other
0.447	Other
61.6_%_in_group_AB	Other
61.6_%	Other
divided	Other
two_groups_including_196_patients_in_group_AB	Other
group_AB	Other
proportional_hazard_regression_analysis	Other
HER2-positive_BCs_treated_from_2008_to_2017	Other
women_with_BCs	Other
women_with_HER2-positive_BCs_treated_with_trastuzumab	Other
women_with_HER2-positive_BCs_treated	Other
women_with_HER2-positive_BCs_treated_from_2008_to_2017	Other
women_with_BCs_treated_with_trastuzumab	Other
women_with_BCs_treated	Other
nAB_regimen	Other
women_with_HER2-positive_BCs	Other
0.630	Other
group_nAB	Other
women_with_HER2-positive_BCs_treated_with_trastuzumab_from_2008_to_2017	Other
two_groups_including_196_patients	Other
women_with_BCs_treated_with_trastuzumab_from_2008_to_2017	Other
women_with_BCs_treated_from_2008_to_2017	Other
human_epidermal_growth_factor_receptor_2	Other
women	Species
planned_prognosis_discussion	Other
patients_with_advanced_breast_cancer_as_valuable	Other
patients_with_breast_cancer_as_valuable	Other
can_delivered_effectively_by_team	Other
appointment	Other
patients_with_advanced_breast_cancer	Other
can_delivered_by_practice-based_team_within_semi-structured_patient_education_appointment	Other
can_delivered_effectively_by_practice-based_team	Other
likely	Other
can_delivered_effectively_by_team_within_patient_education_appointment	Other
patients	Species
T-PAT_appointment	Other
conducted	Other
can_delivered_effectively_by_practice-based_clinical_team	Other
intervention_feasibility	Other
realistic_beliefs	Other
breast_cancer	Other
patients_as_valuable	Other
more_likely	Other
can_delivered_effectively_by_team_within_semi-structured_patient_education_appointment	Other
perceived	Other
can_delivered_effectively_by_practice-based_clinical_team_within_semi-structured_patient_education_appointment	Other
intervention	Other
can_delivered_by_team	Other
can_delivered_by_clinical_team_within_semi-structured_patient_education_appointment	Other
can_delivered_by_practice-based_team_within_patient_education_appointment	Other
can_delivered_effectively	Other
can_delivered_effectively_by_clinical_team_within_patient_education_appointment	Other
can_delivered_by_team_within_patient_education_appointment	Other
advanced_breast_cancer	Other
can_delivered	Other
compared	Other
prognosis_discussion	Other
can_delivered_effectively_by_clinical_team_within_semi-structured_patient_education_appointment	Other
can_delivered_by_clinical_team_within_patient_education_appointment	Other
prognosis_discussion_communication_skills	Other
can_delivered_by_practice-based_clinical_team_within_semi-structured_patient_education_appointment	Other
beliefs_about_disease_curability	Other
can_delivered_by_clinical_team	Other
can_delivered_by_team_within_semi-structured_patient_education_appointment	Other
patients_with_breast_cancer	Other
can_delivered_effectively_by_practice-based_team_within_patient_education_appointment	Other
beliefs	Other
can_delivered_effectively_by_practice-based_team_within_semi-structured_patient_education_appointment	Other
can_delivered_by_practice-based_team	Other
intervention_easy	Other
can_delivered_by_practice-based_clinical_team_within_patient_education_appointment	Other
realistic_beliefs_about_disease_curability	Other
can_delivered_effectively_by_practice-based_clinical_team_within_patient_education_appointment	Other
can_delivered_effectively_by_clinical_team	Other
can_delivered_by_practice-based_clinical_team	Other
utilization_of_acid_for_breast_cancer_therapy	Other
novel_utilization_of_3-O-p-coumaroyltormentic_acid_via_disruption	Other
novel_utilization	Other
paradigm	Other
dose-dependent_manner	Other
utilization_of_3-O-p-coumaroyltormentic_acid_for_breast_cancer_therapy	Other
utilization_for_breast_cancer_therapy	Other
novel_utilization_for_breast_cancer_therapy_via_disruption	Other
phytochemicals	Other
manner	Other
novel_utilization_of_acid_via_disruption	Other
novel_utilization_of_acid	Other
novel_utilization_via_disruption	Other
expression_of_self-renewal-related_genes	Other
cancer_prevention	Other
utilization_of_3-O-p-coumaroyltormentic_acid	Other
isolation_of_one_compound	Other
utilization_of_3-O-p-coumaroyltormentic_acid_via_disruption	Other
novel_utilization_of_3-O-p-coumaroyltormentic_acid_for_breast_cancer_therapy_via_disruption	Other
novel_utilization_of_3-O-p-coumaroyltormentic_acid_for_breast_cancer_therapy	Other
utilization_of_3-O-p-coumaroyltormentic_acid_for_breast_cancer_therapy_via_disruption	Other
utilization_of_acid_via_disruption	Other
drug-resistant	Other
cell_population	Other
novel_utilization_of_acid_for_breast_cancer_therapy_via_disruption	Other
utilization_via_disruption	Other
new	Other
breast_cancer_cell_proliferation	Other
utilization_of_acid	Other
expression	Other
expression_of_genes	Other
isolation	Other
novel_utilization_of_acid_for_breast_cancer_therapy	Other
utilization	Other
new_paradigm	Other
utilization_for_breast_cancer_therapy_via_disruption	Other
CD44high/CD24low_subpopulation	Other
ALDH	Other
novel_utilization_of_3-O-p-coumaroyltormentic_acid	Other
utilization_of_acid_for_breast_cancer_therapy_via_disruption	Other
aldehyde_dehydrogenase	Other
novel_utilization_for_breast_cancer_therapy	Other
results_of_studies_published	Other
15_fractions_for_total_dose	Other
assessed	Other
results_of_other_studies_published	Other
phase_II_trial	Other
results_of_other_studies	Other
excellent/good	Other
association_of_chemotherapy	Other
VMAT-SIB_technique	Other
association	Other
51.1_%_of_patients_G2	Other
results_of_studies_published_on_association_of_hypofractionation	Other
15_fractions_for_dose	Other
13.5_%_of_patients	Other
9.7_%	Other
end_of_RT_treatment_skin_toxicity	Other
results_of_other_studies_published_on_association_of_hypofractionation	Other
terms	Other
51.1_%_of_patients_G2_in_9.7_%	Other
end	Other
association_with_boost	Other
terms_of_acute	Other
results	Other
enrolled	Other
results_of_other_studies_published_on_association	Other
patients	Species
results_of_studies	Other
also_assessed	Other
association_of_chemotherapy_with_boost	Other
recorded	Other
51.1_%_of_patients	Other
at_least_2_year_follow-up	Other
breast_cancer	Other
15_fractions	Other
results_of_studies_published_on_association	Other
safe	Other
boost	Other
51.1_%	Other
breast	Other
early-stage_breast_cancer	Other
whole_breast	Other
recurrence_risk_beyond_5_years_after_diagnosis	Other
tumors_showing	Other
late_recurrence	Other
patients_with_tumors_showing	Other
late_recurrence_biology_trials	Other
recurrences_occurring	Other
treatment_extension	Other
ER-positive/human_epidermal_growth_factor_receptor_2-negative_breast_cancer	Other
knowledge_of_recurrence_biology_clinical_trials_on_endocrine_therapy	Other
estrogen_receptor	Other
setting	Other
early_recurrence_risk	Other
endocrine_therapy	Other
benefit_from_endocrine_therapy	Other
late_recurrence_from_treatment_extension	Other
prognostic_for_late_recurrence_selection_tools	Other
knowledge	Other
recurrence_biology_clinical_trials	Other
high_expression_of_estrogen-responsive_genes	Other
recurrences_in_patients_with_tumors	Other
5_years_of_tamoxifen_therapy_with_5_years_of_tamoxifen	Other
high_recurrence_risk_beyond_5_years	Other
genes	Other
analysis	Other
knowledge_of_late_recurrence_biology_trials_on_extended_endocrine_therapy	Other
knowledge_of_recurrence_biology_trials	Other
benefit	Other
recurrence	Other
prognostic	Other
recurrence_biology_trials	Other
knowledge_of_late_recurrence_biology_trials_on_endocrine_therapy	Other
late_recurrences_in_patients_with_tumors	Other
late_recurrence_biology_clinical_trials	Other
recurrence_selection_tools	Other
their_association_with_recurrence_risk	Other
estrogen-responsive_genes	Other
knowledge_of_recurrence_biology_clinical_trials_on_extended_endocrine_therapy	Other
recurrences	Other
knowledge_of_late_recurrence_biology_trials	Other
prognostic_for_recurrence_selection_tools	Other
applied	Other
recurrence_risk_beyond_5_years	Other
crucial	Other
knowledge_on_extended_endocrine_therapy	Other
patient_selection	Other
high_recurrence_risk	Other
pooled_analysis	Other
their_association	Other
recurrence_risk	Other
late_recurrence_selection_tools	Other
treatment_cessation	Other
5_years_of_tamoxifen	Other
5_years_with_5_years_of_tamoxifen	Other
5_years	Other
recurrence_from_treatment_extension	Other
years_of_endocrine_therapy_reduced	Other
knowledge_of_late_recurrence_biology_clinical_trials_on_endocrine_therapy	Other
knowledge_of_recurrence_biology_trials_on_endocrine_therapy	Other
late_recurrences_in_patients	Other
knowledge_of_recurrence_biology_clinical_trials	Other
knowledge_of_late_recurrence_biology_clinical_trials	Other
high_recurrence_risk_beyond_5_years_after_diagnosis	Other
recurrences_in_patients	Other
ER-driven	Other
benefit_from_extended_endocrine_therapy	Other
late_recurrences	Other
their_association_with_early_recurrence_risk	Other
5_years_of_endocrine_therapy_reduced	Other
knowledge_on_endocrine_therapy	Other
knowledge_of_recurrence_biology_trials_on_extended_endocrine_therapy	Other
5_years_with_5_years	Other
5_years_of_tamoxifen_therapy_with_5_years	Other
likely_ER-driven	Other
5_years_of_tamoxifen_therapy	Other
associated	Other
pathway	Other
extended_endocrine_therapy	Other
toxicity	Disease
backbone_of_treatment_in_cases	Other
progression_free_survival	Other
initiation_of_chemotherapy_long_term_overall_survival_data_are_lacking	Other
management_challenges_in_treatment_of_advanced_HR_HER2_negative_breast_cancer	Other
HR_positive_breast_cancer_PI3K_inhibitors	Other
backbone_in_cases	Other
sequencing	Other
treatment_of_advanced_HR_positive_HER2_negative_breast_cancer_highlighting	Other
development_of_new_generation_of_therapies_for_breast_cancer	Other
patients_with_hormone_receptor	Other
outcomes	Other
continue	Other
review	Other
potential_biomarkers	Other
hormone_receptor	Other
anticipated	Other
mechanisms	Other
growth_pathway_in_HR_positive_breast_cancer_PI3K_inhibitors	Other
management_challenges_in_treatment	Other
progression_survival	Other
development_of_generation_of_targeted_therapies_for_advanced_breast_cancer	Other
HR_positive_metastatic_breast_cancer	Other
important_growth_pathway_in_HR_breast_cancer_PI3K_inhibitors	Other
development	Other
initiation_of_chemotherapy_term_overall_survival_data_are_lacking	Other
care_allowing	Other
management_challenges_in_treatment_of_HR_HER2_breast_cancer	Other
patients	Species
development_of_new_generation_of_targeted_therapies	Other
supportive_care_allowing	Other
management_challenges_in_treatment_of_advanced_HR_HER2_breast_cancer	Other
backbone_of_treatment	Other
important_growth_pathway_in_HR_positive_breast_cancer_PI3K_inhibitors	Other
ET	Other
initiation_of_chemotherapy_long_term_survival_data_are_lacking	Other
important	Other
cyclin_dependent_kinase	Other
initiation_are_lacking	Other
management_challenges_in_treatment_of_HR_positive_HER2_breast_cancer	Other
care	Other
treatment	Other
management_challenges_in_treatment_of_advanced_HR_positive_HER2_negative_breast_cancer	Other
management_challenges_in_treatment_of_HR_positive_HER2_negative_breast_cancer	Other
unclear	Other
ideal_strategy	Other
initiation_of_chemotherapy_term_survival_data_are_lacking	Other
management_challenges	Other
life	Other
development_of_generation_of_therapies_for_advanced_breast_cancer	Other
development_of_new_generation_of_therapies	Other
development_of_new_generation_of_therapies_for_advanced_breast_cancer	Other
growth_pathway	Other
known	Other
have_disappointing_due_to_modest_effect_sizes	Other
backbone	Other
have_disappointing_due_to_effect_sizes	Other
development_of_generation_of_therapies_for_breast_cancer	Other
effectiveness	Other
development_of_generation_of_targeted_therapies	Other
development_of_new_generation_of_targeted_therapies_for_advanced_breast_cancer	Other
potential_biomarkers_of_resistance	Other
cases	Other
cases_improving	Other
development_of_new_generation_of_targeted_therapies_for_breast_cancer	Other
selective_estrogen_receptor_modulators	Other
management_challenges_in_treatment_of_HR_HER2_negative_breast_cancer	Other
important_growth_pathway	Other
have_disappointing	Other
have_disappointing_due	Other
less_toxicity	Other
development_of_generation	Other
growth_pathway_in_HR_breast_cancer_PI3K_inhibitors	Other
development_of_generation_of_targeted_therapies_for_breast_cancer	Other
supportive_care	Other
management_challenges_in_treatment_of_advanced_HR_positive_HER2_breast_cancer	Other
development_of_new_generation	Other
development_of_generation_of_therapies	Other
clinic	Other
strategy	Other
0.009	Other
questionnaire	Other
sexuality	Other
dysfunctional_excitement	Other
their_sexual_relations	Other
women_with_breast_cancer	Other
514_women_with_breast_cancer	Other
0.002	Other
Sexual_Function	Other
function	Other
Women_'s_Sexual_Function	Other
4.05_±_5.23_years	Other
42.26_±_8.56_years	Other
50.6_%	Other
satisfied	Other
function_of_women	Other
June_2016	Other
gathered	Other
penetration_pain	Other
their_relations	Other
excitement	Other
breast_cancer	Other
important	Other
514_women	Other
sexual_function_of_women	Other
due	Other
sexual_function	Other
46.34_±_8.28_years	Other
penetration_pain_desire_lubrication	Other
cancer	Disease
±_standard_deviation_SD	Other
women	Species
changed	Other
coregulators_of_specific_protein_complexes	Other
Thus_may_key_factor_in_progression_of_breast_cancer	Other
may_key_factor	Other
related_to_therapy_resistance	Other
development_of_mammary_tumors	Other
may_factor	Other
endocrine_therapy_resistance	Other
may_factor_in_progression	Other
development_of_tumors	Other
related	Other
ERα_protein_levels	Other
induced	Other
responsible	Other
inhibited	Other
breast_cancers	Other
Thus_may_factor	Other
Moreover_related	Other
key	Other
linked	Other
development	Other
ERα	Other
Thus_may_factor_in_progression_of_breast_cancer	Other
therapy_resistance	Other
increase	Other
may_key_factor_in_progression	Other
coactivators	Other
may_factor_in_progression_of_breast_cancer	Other
related_to_endocrine_therapy_resistance	Other
Thus_may_key_factor_in_progression	Other
progression_of_breast_cancer	Other
Thus_may_factor_in_progression	Other
ubiquitin_proteasome_system	Other
estradiol_hormone	Other
detected	Other
Thus_may_key_factor	Other
ERα_degradation	Other
ERα_transcription_cycle	Other
increase_in_ERα_protein_levels	Other
coactivators_for_ERα	Other
may_key_factor_in_progression_of_breast_cancer	Other
easy_time-efficient_cost-effective	Other
easy_cost-effective	Other
interstitial_fractionated_multicatheter_brachytherapy	Other
12_%	Other
high	Other
Objective_Breast_Cosmesis_Scale	Other
breast_irradiation	Other
easy_reproducible_cost-effective	Other
fractionated_brachytherapy	Other
brachytherapy	Other
fractionated_multicatheter_high-dose-rate_brachytherapy	Other
interstitial_brachytherapy	Other
interstitial_fractionated_brachytherapy	Other
interstitial_multicatheter_brachytherapy	Other
OBCS	Other
high_between_trainees_before_treatment	Other
changes_in_breast_cosmesis	Other
interstitial_fractionated_multicatheter_high-dose-rate_brachytherapy	Other
high-dose-rate_brachytherapy	Other
fractionated_multicatheter_brachytherapy	Other
future_studies	Other
high_treatment	Other
photographs	Other
investigation_in_future_studies	Other
interstitial_multicatheter_high-dose-rate_brachytherapy	Other
reproducible_cost-effective	Other
easy_time-efficient_reproducible_cost-effective	Other
further_investigation_in_future_studies	Other
13_%_to_21.4_%	Other
treatment	Other
adjuvant_accelerated_breast_irradiation	Other
trainees	Other
cost-effective	Other
12_%_to_26.5_%	Other
changes	Other
accelerated_breast_irradiation	Other
breast_cosmesis	Other
fractionated_high-dose-rate_brachytherapy	Other
12_%_before_treatment	Other
adjuvant_partial_breast_irradiation	Other
adjuvant_breast_irradiation	Other
time-efficient_reproducible_cost-effective	Other
accelerated_partial_breast_irradiation	Other
patient	Species
distances_between_anatomic_features	Other
further_investigation	Other
multicatheter_high-dose-rate_brachytherapy	Other
adjuvant_accelerated_partial_breast_irradiation	Other
enrolled	Other
multicatheter_brachytherapy	Other
13_%	Other
12_%_to_26.5_%_before_treatment	Other
distances	Other
interstitial_high-dose-rate_brachytherapy	Other
high_between_trainees_treatment	Other
13_%_to_21.4_%_afterward	Other
partial_breast_irradiation	Other
analyzed	Other
interstitial_fractionated_high-dose-rate_brachytherapy	Other
recorded	Other
nonstandardized_photographs	Other
high_before_treatment	Other
distances_between_features	Other
breast-conserving_surgery	Other
two_radiation_oncology_centers	Other
investigation	Other
time-efficient_cost-effective	Other
surgery	Other
measured	Other
have_linked	Other
pivotal_role	Other
antagonism	Other
pivotal_role_of_IR_antagonist_S961_on_IR_signalling	Other
distinct_antagonism	Other
cellular_proliferation	Other
breast_cancer_pathogenesis	Other
continued_presence	Other
breast_tumour_cells	Other
MTT	Chemical
downregulated	Other
aspects_of_phenotype_including_cell_proliferation	Other
have_linked_to_pathogenesis_of_breast_carcinoma	Other
several_aspects_of_malignant_phenotype_including_cell_proliferation	Other
several_aspects_of_phenotype_including_cell_proliferation	Other
role_of_IR_antagonist_S961_on_IR_signalling_in_MCF-7_MDA-MB-231	Other
aspects_of_malignant_phenotype	Other
evaluated	Other
expression_of_IRs	Other
aspects_of_phenotype	Other
presence	Other
IR-A_isoform	Other
several_aspects_of_malignant_phenotype	Other
have_intricately_linked_to_pathogenesis	Other
extensive_growth	Other
several_aspects	Other
pivotal_role_on_IR_signalling	Other
presence_of_insulin	Other
proliferation_in_breast_tumour_cells	Other
even_presence	Other
aimed	Other
aspects_of_malignant_phenotype_including_cell_proliferation	Other
dose	Other
have_intricately_linked	Other
colony_formation	Other
PCR	Other
role	Other
breast_carcinoma_cells	Other
role_on_IR_signalling	Other
pivotal_role_on_IR_signalling_in_MCF-7_MDA-MB-231	Other
quantitative_PCR	Other
aspects	Other
MCF-7_MDA-MB-231	Other
even_presence_of_insulin	Other
role_of_IR_antagonist_S961_on_IR_signalling	Other
pivotal_role_of_IR_antagonist_S961	Other
IR_overexpression	Other
presence_of_S961	Other
found	Other
nanomolar_dose	Other
have_linked_to_pathogenesis	Other
have_intricately_linked_to_pathogenesis_of_breast_carcinoma	Other
expression	Other
proliferation	Other
continued_presence_of_S961	Other
IRs	Other
role_on_IR_signalling_in_MCF-7_MDA-MB-231	Other
cellular_proliferation_in_breast_tumour_cells	Other
pivotal_role_of_IR_antagonist_S961_on_IR_signalling_in_MCF-7_MDA-MB-231	Other
significantly_downregulated	Other
role_of_IR_antagonist_S961	Other
several_aspects_of_phenotype	Other
growth	Other
proliferation_owing	Other
breast_conservation_therapy	Other
might_involved	Other
breast_cancer_patients	Other
study_2	Other
approximately_3_years	Other
2_×_2_mixed	Other
Pearson_'s_correlation_coefficient	Other
plasma_IL-6_levels	Other
unclear	Other
WMS-R_indices_between_two_studies	Other
might_involved_in_recovery_process	Other
Wechsler_Memory_Scale-Revised_test	Other
that	Other
soon_restored	Other
cognitive_decline	Other
Wechsler_Memory_test	Other
decline	Other
restored	Other
correlation_coefficient	Other
evaluated	Other
higher	Other
significantly_higher	Other
three_metrics	Other
three_different_metrics	Other
three_representations_of_breast_cancer_patient_cohorts	Other
three_visual_representations	Other
three_representations	Other
three_visual_representations_of_breast_cancer_patient_cohorts	Other
three_metrics_of_mortality	Other
three_representations_of_SEER-based_breast_cancer_patient_cohorts	Other
three_visual_representations_of_SEER-based_breast_cancer_patient_cohorts	Other
three_different_metrics_of_mortality	Other
highest_responsive_gene	Other
its_transcription	Other
have_implicated_in_promotion	Other
poor_clinical_outcomes	Other
reduction_in_breast_cancer_growth	Other
However_required	Other
required	Other
poor_outcomes	Other
mouse	Species
TAMs	Other
outcomes	Other
breast_cancer_lymph_node_metastasis	Other
loop	Other
further_investigation	Other
significantly_correlated	Other
breast_cancer_metastasis	Other
have_identified	Other
still_required	Other
SOX4	Gene
highest_gene	Other
gene	Other
NF-κB/SOX4_activation	Other
significant_reduction	Other
breast_cancer_growth	Other
CXCL1_administration	Other
significant_reduction_in_breast_cancer_growth	Other
However_still_required	Other
have_implicated	Other
investigation	Other
loop_TAMs	Other
SOX4_promoter	Other
have_implicated_in_promotion_of_breast_cancer_growth	Other
reduction	Other
correlated	Other
clinical_outcomes	Other
responsive_gene	Other
combination_therapy_for_patients_with_advanced_recurrent_breast_cancer	Other
Level_0_doses	Other
combination_therapy_due_to_toxicities	Other
combination_therapy_for_patients_with_breast_cancer_due_to_hematological_toxicities	Other
combination_therapy	Other
escalated_to_1.4_mg/m2_for_GEM	Other
only_1_patient	Other
phase	Other
combination_therapy_for_patients_with_advanced_breast_cancer	Other
combination_therapy_due_to_hematological_toxicities	Other
combination_therapy_for_patients_with_advanced_recurrent_breast_cancer_due	Other
combination_therapy_for_patients_with_breast_cancer_due_to_toxicities	Other
escalated	Other
difficult	Other
combination_therapy_for_patients_due	Other
Grade_3_mucositis	Other
combination_therapy_for_patients_due_to_hematological_toxicities	Other
GEM	Chemical
tolerability_of_combination_therapy	Other
combination_therapy_for_patients_with_advanced_recurrent_breast_cancer_due_to_toxicities	Other
tolerability_of_combination_therapy_with_ERI	Other
combination_therapy_for_patients_with_recurrent_breast_cancer	Other
combination_therapy_for_patients_with_advanced_breast_cancer_due	Other
combination_therapy_due	Other
Level_1_doses	Other
ERI	Other
escalated_to_1.4_mg/m2_for_ERI_for_GEM	Other
combination_therapy_for_patients	Other
combination_therapy_for_patients_with_recurrent_breast_cancer_due_to_hematological_toxicities	Other
metastatic_breast_cancer	Other
Japanese_patients_with_metastatic_breast_cancer	Other
combination_therapy_for_patients_with_advanced_recurrent_breast_cancer_due_to_hematological_toxicities	Other
conclusion	Other
combination_therapy_for_patients_with_advanced_breast_cancer_due_to_hematological_toxicities	Other
found	Other
advanced_recurrent_breast_cancer	Other
combination_therapy_for_patients_with_breast_cancer	Other
1.4_mg/m2_for_ERI	Other
combination_therapy_for_patients_with_recurrent_breast_cancer_due_to_toxicities	Other
other_chemotherapeutic_agents	Other
has_approved	Other
combination_therapy_for_patients_with_breast_cancer_due	Other
tolerability_with_ERI	Other
Grade_3_oral_mucositis	Other
1.4_mg/m2	Other
combination_therapy_for_patients_with_recurrent_breast_cancer_due	Other
Level_0	Other
combination_with_other_chemotherapeutic_agents	Other
combination_therapy_for_patients_due_to_toxicities	Other
tolerability	Other
Level_1	Other
combination_therapy_for_patients_with_advanced_breast_cancer_due_to_toxicities	Other
only_1_patient_of_Level_1_group	Other
molecular_pathways_involved_in_pathogenesis_of_proliferation	Other
death	Disease
cancer-related_death	Other
molecular_pathways_involved	Other
frequently_occurring_cancer	Other
most_frequently_occurring_cancer	Other
that	Other
their_potential_clinical_implications_on_breast_cancer	Other
review	Other
molecular_pathways_involved_in_pathogenesis	Other
closed_loop_structure	Other
knowledge	Other
knowledge_on_human_circRNAs	Other
molecular_pathways	Other
their_potential_implications	Other
current_knowledge	Other
their_potential_implications_on_breast_cancer	Other
pathways_involved_in_pathogenesis	Other
pathways	Other
pathways_involved_in_pathogenesis_of_proliferation	Other
current_knowledge_on_circRNAs	Other
women_worldwide	Other
knowledge_on_circRNAs	Other
their_potential_clinical_implications	Other
current_knowledge_on_human_circRNAs	Other
cancer	Disease
vital	Other
occurring_cancer	Other
pathways_involved	Other
women	Species
	Other
